Comera Life Sciences Holdings, Inc. – NASDAQ:CMRA

Add to watchlist

Market closed

Open in 1 day

-100.00%

month

-100.00%

quarter

-100.00%

year

Market Cap	3.07K
Enterprise value	8.68M

P/E	-0.48
EV/Sales	13.72
EV/EBITDA	-0.48
Price/Sales	13.20
Price/Book	-1.33
PEG ratio	N/A
EPS	-4.53

Revenue	1.00M
EBITDA	-9.06M
Income	-84.25M
Revenue Q/Q	-41.97%
Revenue Y/Y	81.78%

Profit margin	-2843.79%
Oper. margin	-1890.69%
Gross margin	66.77%
EBIT margin	-1890.69%
EBITDA margin	-906.63%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA): Profit margin
Dec 2022	156.12K	-2.91M	-1867.86%
Mar 2023	392.91K	-77.77M	-19793.42%
Jun 2023	315.05K	-1.41M	-448.06%
Sep 2023	136.31K	-2.15M	-1580.01%

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA): Debt to assets
Dec 2022	3727113	9.97M	267.61%
Mar 2023	2999117	8.26M	275.55%
Jun 2023	2340172	8.69M	371.36%
Sep 2023	3071949	7.29M	237.39%

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA): Cash Flow
Dec 2022	-1.84M	-28.57M	1.13M
Mar 2023	-1.90M	-88.35K	1.58M
Jun 2023	-993.50K	-5.65K	-63.19K
Sep 2023	-1.91M	0	3.20M

Comera Life Sciences Holdings alternative data

Comera Life Sciences Holdings
Employees

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA): Employee count
Aug 2023	12
Sep 2023	12
Oct 2023	12
Nov 2023	12
Dec 2023	12
Jan 2024	12
Feb 2024	12
Mar 2024	12
Apr 2024	12
May 2024	12
Jun 2024	12
Jul 2024	12

Comera Life Sciences Holdings
Hedge Funds Holdings Q1 2023

0.72% -2.55%

of CMRA is owned by hedge funds

6 -6

hedge funds hold CMRA stock

74.86K -448.29K

shares is hold by hedge funds

CMRA hedge funds holdings changes

Comera Life Sciences Holdings
Insider Trading

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA): Insider trades (number of shares)
Period	Buy	Sel
Jan 2023	2089518	0
Jul 2023	479217	0
Aug 2023	20000	0
Sep 2023	7393642	0
Nov 2023	10000	0
Dec 2023	91396132	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	29 Dec 2023	SOANE DAVID 10 percent owner 10 percent owner	Warrant (right to buy)	5,454,544	$0.06	$300,000
Purchase	29 Dec 2023	CHERINGTON CHARLES 10 percent owner 10 percent owner	Warrants to Purchase Common Stock	41,301,816	$0.06	$2,271,600
Purchase	29 Dec 2023	CHERINGTON CHARLES 10 percent owner 10 percent owner	12.0% Senior Secured Convertible Notes	0	$0.06	$0
Purchase	29 Dec 2023	SOANE DAVID 10 percent owner 10 percent owner	12% Senior Secured Convertible Note	2,727,272	$0.06	$150,000
Purchase	29 Dec 2023	IAF, LLC	Warrants to Purchase Common Stock	15,272,724	$0.06	$840,000
Purchase	29 Dec 2023	IAF, LLC	12.0% Senior Secured Convertible Notes	0	$0.06	$0
Purchase	29 Dec 2023	FREEBIRD PARTNERS LP 10 percent owner 10 percent owner	Common Stock Purchase Warrant	9,814,544	$0.06	$539,800
Purchase	29 Dec 2023	FREEBIRD PARTNERS LP 10 percent owner 10 percent owner	Convertible Note Shares	4,907,272	$0.06	$269,900
Purchase	29 Dec 2023	DENNY GEORGE P III	Warrants to Purchase Common Stock	7,827,052	$0.06	$430,488
Purchase	29 Dec 2023	DENNY GEORGE P III	12.0% Senior Secured Convertible Notes	0	$0.06	$0

CMRA insider trading transactions

Comera Life Sciences Holdings
Latest News

Thursday, 4 January 2024
08:30	Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option	globenewswire.com
Wednesday, 6 December 2023
08:30	Comera Life Sciences Announces Process Exploring Strategic Alternatives	globenewswire.com
Monday, 13 November 2023
08:00	Comera Life Sciences Appoints Dorothy Clarke to Board of Directors	globenewswire.com
Thursday, 9 November 2023
08:00	Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights	globenewswire.com
Monday, 16 October 2023
08:00	Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference	globenewswire.com
Saturday, 26 August 2023
15:21	These Are the ONLY 7 Penny Stocks to Consider in August 2023	InvestorPlace
Thursday, 12 January 2023
16:15	Comera Life Sciences to Present at 22nd Annual PepTalk Conference	GlobeNewsWire
Thursday, 17 November 2022
16:05	Comera Life Sciences to Participate in the Benchmark Company's Upcoming Discovery One-on-One Investor Conference	GlobeNewsWire
Thursday, 15 September 2022
13:52	3 Hot Penny Stocks To Buy According To Insiders In September	PennyStocks
Wednesday, 14 September 2022
06:00	Top Penny Stocks to Watch After the Market Crash	PennyStocks
Tuesday, 13 September 2022
14:33	Insiders Are Buying Up Comera Life Sciences (CMRA) Stock. Here's Why.	InvestorPlace
Thursday, 28 July 2022
11:30	Best Penny Stocks To Buy As Recession Begins? 5 Biotech Stocks To Watch	PennyStocks
Tuesday, 26 July 2022
20:10	Best Penny Stocks To Buy? 4 To Watch After PGY Stock Explodes 790%	PennyStocks
Friday, 17 June 2022
17:05	3 Top Stocks To Watch Before Next Week	PennyStocks

Frequently Asked Questions (FAQ)

What's the price of Comera Life Sciences Holdings stock today?

One share of Comera Life Sciences Holdings stock can currently be purchased for approximately $0.
When is Comera Life Sciences Holdings's next earnings date?

Unfortunately, Comera Life Sciences Holdings's (CMRA) next earnings date is currently unknown.
Does Comera Life Sciences Holdings pay dividends?

No, Comera Life Sciences Holdings does not pay dividends.
How much money does Comera Life Sciences Holdings make?

Comera Life Sciences Holdings has a market capitalization of 3.07K and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 97.95% to 633.1K US dollars.
What is Comera Life Sciences Holdings's stock symbol?

Comera Life Sciences Holdings, Inc. is traded on the NASDAQ under the ticker symbol "CMRA".
What is Comera Life Sciences Holdings's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Comera Life Sciences Holdings?

Shares of Comera Life Sciences Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Comera Life Sciences Holdings have?

As Jul 2024, Comera Life Sciences Holdings employs 12 workers.
When Comera Life Sciences Holdings went public?

Comera Life Sciences Holdings, Inc. is publicly traded company for more then 4 years since IPO on 21 Dec 2020.
What is Comera Life Sciences Holdings's official website?

The official website for Comera Life Sciences Holdings is comeralifesciences.com.
Where are Comera Life Sciences Holdings's headquarters?

Comera Life Sciences Holdings is headquartered at 12 Gill Street, Woburn, MA.
How can i contact Comera Life Sciences Holdings?

Comera Life Sciences Holdings's mailing address is 12 Gill Street, Woburn, MA and company can be reached via phone at +61 78712101.

Comera Life Sciences Holdings, Inc.

comeralifesciences.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

+61 78712101

12 Gill Street
Woburn, MA 01801

CIK: 0001907685
ISIN: US20037C1080
CUSIP: 20037C108